PT
Autoridade da Concorrência

Case details

Print
Merger control
Case reference
Ccent/2023/45 - Bain Capital / FIS
Acquiring
Bain Capital Investors L.L.C
Description
American private equity firm that invests, through its family of funds, in companies across a range of sectors, including information technology, healthcare, retail and consumer products, communications, financial services and manufacturing.
Acquired
F.I.S. Fabbrica Italiana Sintetici S.p.A.
Description
Italian company specialized in the production of chemical products for the pharmaceutical industry, in particular in the provision of contract development and manufacturing organization exploration and production services and focuses on providing these services for active pharmaceutical ingredients for medicines intended for human and veterinary use.
Sector
  • Health & Pharmaceutical
Activity (NACE)
  • C2120 - Manufacture of pharmaceutical preparations
Applicable legislation
Art. 37(1)(c) (Law 19)
Notification thresholds
Turnover threshold
Type of merger
Conglomerate
Cooperation with sector regulators
Status
Closed
Type of Investigation
Phase 1
AdC’s decision
Non-opposition
Case description

This notification concerns the acquisition of sole control of F.I.S. Fabbrica Italiana Sintetici S.p.A. ("FIS") by funds managed or advised by branches of Bain Capital Investors L.L.C. ("Bain Capital").
Timeline
2023-09-06
The AdC issued a non-opposition decision to the merger Bain Capital / FIS.
2023-08-14
Bain Capital notifies the acquisition of exclusive control over F.I.S. Fabbrica Italiana Sintetici.
Click here to see your activities